CymaBay submits New Drug Application for PBC treatment
Seeking a Priority Review designation, CymaBay anticipates that the FDA will conclude its evaluation of the PBC treatment within six months.
Julia Cipriano, MS
Julia Cipriano, MS, is a scientific journalist who has authored over a thousand relevant online news publications, as well as several journal articles. She holds a BS from Molloy University and an MS from Eastern Illinois University, both in Biological Sciences. Julia kicked off her career in medical communications as a clinical report writer for The Estée Lauder Companies and further honed her skills in the field as a medical oncology writer for the Journal of the National Comprehensive Cancer Network.
